| Patricia Marsh, | |
|
3999 Austell Rd Ste 901, Austell, GA 30106-1160 | |
| (770) 809-3032 | |
| (678) 838-6797 |
| Full Name | Patricia Marsh |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 3999 Austell Rd Ste 901, Austell, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184085649 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 78153 (Georgia) | Primary |
| Entity Name | The Southeast Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245266956 PECOS PAC ID: 6204829013 Enrollment ID: O20040407000370 |
News Archive
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.
A small peptide dubbed TAxI is living up to its name. Recent studies show it to be an effective vehicle for shuttling functional proteins, such as active enzymes, into the spinal cord after a muscle injection.
A number of new technologies and surgical techniques promise to "personalize" orthopedic operations such as hip and knee replacement, according to research to be presented at an educational program at Hospital for Special Surgery on October 15 and 16. During "Computer Assisted Orthopaedic Surgery: Review of Emerging Technologies," prominent orthopedic researchers will discuss how innovative technologies can improve surgical outcomes.
Anacor Pharmaceuticals announced today that it has entered into a loan agreement led by Oxford Finance Corporation and partnered with Horizon Technology Finance Corporation to provide up to $30 million in capital. Anacor used $6.6 million to repay the remaining obligations under its loan agreement with Lighthouse Capital Partners and expects to use the remainder of the capital to fund development activities related to AN2690, AN2728 and AN2898.
› Verified 5 days ago
| Entity Name | Wellstreet Of Georgia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235411547 PECOS PAC ID: 7517126279 Enrollment ID: O20120315000603 |
News Archive
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.
A small peptide dubbed TAxI is living up to its name. Recent studies show it to be an effective vehicle for shuttling functional proteins, such as active enzymes, into the spinal cord after a muscle injection.
A number of new technologies and surgical techniques promise to "personalize" orthopedic operations such as hip and knee replacement, according to research to be presented at an educational program at Hospital for Special Surgery on October 15 and 16. During "Computer Assisted Orthopaedic Surgery: Review of Emerging Technologies," prominent orthopedic researchers will discuss how innovative technologies can improve surgical outcomes.
Anacor Pharmaceuticals announced today that it has entered into a loan agreement led by Oxford Finance Corporation and partnered with Horizon Technology Finance Corporation to provide up to $30 million in capital. Anacor used $6.6 million to repay the remaining obligations under its loan agreement with Lighthouse Capital Partners and expects to use the remainder of the capital to fund development activities related to AN2690, AN2728 and AN2898.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Marsh, 711 Cosmopolitan Dr Ne Unit 129, Atlanta, GA 30324-3617 Ph: (267) 319-2780 | Patricia Marsh, 3999 Austell Rd Ste 901, Austell, GA 30106-1160 Ph: (770) 809-3032 |
News Archive
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.
A small peptide dubbed TAxI is living up to its name. Recent studies show it to be an effective vehicle for shuttling functional proteins, such as active enzymes, into the spinal cord after a muscle injection.
A number of new technologies and surgical techniques promise to "personalize" orthopedic operations such as hip and knee replacement, according to research to be presented at an educational program at Hospital for Special Surgery on October 15 and 16. During "Computer Assisted Orthopaedic Surgery: Review of Emerging Technologies," prominent orthopedic researchers will discuss how innovative technologies can improve surgical outcomes.
Anacor Pharmaceuticals announced today that it has entered into a loan agreement led by Oxford Finance Corporation and partnered with Horizon Technology Finance Corporation to provide up to $30 million in capital. Anacor used $6.6 million to repay the remaining obligations under its loan agreement with Lighthouse Capital Partners and expects to use the remainder of the capital to fund development activities related to AN2690, AN2728 and AN2898.
› Verified 5 days ago
Victoria Randle, NP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 6130 Hotel St, Austell, GA 30106 Phone: 770-726-3577 Fax: 770-522-6228 | |
Dr. Erica Judge Edwards, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1790 Mulkey Rd Ste 8a, Austell, GA 30106 Phone: 770-944-1830 Fax: 770-739-0260 | |
Dr. Shin Long Liao, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-732-4010 | |
Bonnie P Ellenoff, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3640 Tramore Pointe Pkwy, Kaiser Permanente West Cobb Medical Center, Austell, GA 30106 Phone: 770-439-4700 Fax: 404-370-0428 | |
Dr. Ramon Antonio Arias, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4320 Flint Hill Rd, Austell, GA 30106 Phone: 770-778-3378 Fax: 770-437-8070 | |
Dr. Thomas Gearhard, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1790 Mulkey Rd Ste 8a, Austell, GA 30106 Phone: 770-944-1830 Fax: 770-739-0260 |